Join thousands of sector professionals
The Provider Selection Regime – emerging themes
Following major reforms, independent healthcare providers are navigating a new and evolving public procurement landscape. Shailee Howard and Claire Crawford, procurement partners at law...
How can healthtech companies get ahead of AI regulation?
Current regulations shape the use of AI in healthcare and further regulations are on the horizon. Gayle Curry, partner at Mills & Reeve, discusses...
Historic abuse claims: the implications of legislation proposals on health and social care
A proposed new bill to remove the time limitation period for victims to bring claims against historical child sexual abuse puts independent health and...
Learning lessons in healthcare: the evolution of PFD reports
A shift in the coroner’s approach to PFD reports is placing greater pressure on organisations to respond - or risk public scrutiny. With the...
The Employment Rights Bill: redefining recruitment and retention
The new Employment Rights Bill might not be implemented until next year, but the sheer scale of changes it introduces means employers need to...
How to build a long-term and mutually beneficial relationship with the NHS
A ‘new agreement’ between the NHS and private sector will be welcomed by independent healthcare providers, but turning a short-term window of opportunity into...
What does the new digital markets law mean for health and wellness businesses?
Changes to subscription contracts under the Digital Markets, Competition and Consumers Act 2024 ushers in a new era for consumer law and fairness within...
What’s next for medtech?
As developments in AI and personalisation continue to gather momentum, medtech innovation is attracting increased interest from investors. The team at McDermott Will &...
A positive outlook for UK healthcare and life sciences M&A
Healthcare and life sciences investment in the UK is set for a rebound in 2025 as credit markets ease and investor sentiment strengthens, reports...
Trends in UK healthcare M&A
There are encouraging signs of a resurgence of healthcare M&A at the large cap end of the market. Sharon Lamb, partner and head...
©2026 All rights reserved LaingBuisson